Joining a growing litigation, a Mississippi woman recently filed her own lawsuit against Janssen Pharmaceuticals, alleging she has suffered from serious Invokana complications.

The plaintiff, Joann K., began taking Invokana at the direction of her doctor in January 2014 to treat her diabetes. Joann’s Invokana usage continued for several months, until Sept. 19, 2014, when she abruptly had to stop taking the drug due to Invokana complications including a severe kidney injury.

The Invokana lawsuit claims that her kidney injury is a direct result of taking Invokana.

In response, Joann chose to file a lawsuit after suffering these Invokana complications. She claims that Janssen was actually aware of the risk of kidney problems linked with Invokana, yet failed to adequately warn the public and the medical community about these dangers.

The Invokana complications lawsuit was filed on multiple counts, including manufacturing defect, defective design, failure to warn, breach of express and implied warranties, negligence, and fraudulent misrepresentation and concealment, among several others. Joann filed her lawsuit on Sept. 13 in the U.S. District Court for the District of New Jersey.

This complaint joins many other lawsuits filed over Invokana complications to be consolidated into an MDL, or multidistrict litigation. The plaintiff is also seeking punitive damages.

Background of Invokana

Invokana (also known by its generic name, canagliflozin) was first introduced to the drug market in 2013 and is manufactured by Janssen, a prominent subsidiary of pharmaceutical giant Johnson & Johnson. Invokana is one of several major diabetes drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. SGLT2 inhibitor drugs like Invokana are part of a relatively new class of diabetes drugs, but have grown rapidly in popularity.

Despite the popularity of these new diabetes drugs, the U.S. Food and Drug Administration (FDA) has received a slew of adverse event reports regarding Invokana complications and kidney problems, and has since required Janssen to add a series of warnings to the Invokana label about these risks. The warning now urges users to be aware of the link between Invokana and ketoacidosis, and look out for its symptoms including abdominal pain, fatigue, nausea, respiratory problems, and vomiting.

Invokana Complications

Invokana and other diabetes drugs have been connected with a number of dangerous complications, from heart attack to kidney failure to diabetic ketoacidosis.

The popular diabetes drug is associated with a number of Invokana complications, including, but not limited to:

• Dehydration (dizziness, lightheadedness)
• Vaginal yeast infection
• Yeast infection of the penis
• Low blood sugar
• Serious allergic reaction
• Ketoacidosis
• Kidney failure

Filing an Invokana Complications Lawsuit

Invokana lawsuits claim that the drug makers failed to adequately warn about these Invokana complications.

If you or someone you love has suffered due to severe Invokana complications such as kidney injury, you may be able to file a lawsuit. While filing a lawsuit cannot reverse the side effects of Invokana, pursuing an Invokana lawsuit can help to alleviate the financial burden caused by medical expenses and lost wages.

The Invokana Complications Lawsuit is Case No. 3:17-cv-07082-BRM-LHG, in the U.S. District Court for the District of New Jersey.